Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.090
+0.020 (1.87%)
At close: Sep 19, 2025, 4:00 PM EDT
1.105
+0.015 (1.38%)
After-hours: Sep 19, 2025, 7:59 PM EDT
Lucid Diagnostics Employees
Lucid Diagnostics had 72 employees as of December 31, 2024. The number of employees increased by 2 or 2.86% compared to the previous year.
Employees
72
Change (1Y)
2
Growth (1Y)
2.86%
Revenue / Employee
$60,556
Profits / Employee
-$941,917
Market Cap
142.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 72 | 2 | 2.86% |
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LUCD News
- 4 days ago - Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs - PRNewsWire
- 9 days ago - Lucid Diagnostics Announces Closing of Public Offering of Common Stock - PRNewsWire
- 10 days ago - Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PRNewsWire
- 10 days ago - Lucid Diagnostics Announces Proposed Public Offering of Common Stock - PRNewsWire
- 11 days ago - Lucid Diagnostics Inc. (LUCD) Investor Conference Call (Transcript) - Seeking Alpha
- 15 days ago - Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - PRNewsWire
- 24 days ago - Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025 - PRNewsWire
- 25 days ago - PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology - PRNewsWire